ciglitazone has been researched along with Dermatitis, Irritant in 1 studies
ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.
Dermatitis, Irritant: A non-allergic contact dermatitis caused by prolonged exposure to irritants and not explained by delayed hypersensitivity mechanisms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mao-Qiang, M | 1 |
| Fowler, AJ | 1 |
| Schmuth, M | 1 |
| Lau, P | 1 |
| Chang, S | 1 |
| Brown, BE | 1 |
| Moser, AH | 1 |
| Michalik, L | 1 |
| Desvergne, B | 1 |
| Wahli, W | 1 |
| Li, M | 1 |
| Metzger, D | 1 |
| Chambon, PH | 1 |
| Elias, PM | 1 |
| Feingold, KR | 1 |
1 other study available for ciglitazone and Dermatitis, Irritant
| Article | Year |
|---|---|
Peroxisome-proliferator-activated receptor (PPAR)-gamma activation stimulates keratinocyte differentiation.
Topics: Animals; Cell Differentiation; Dermatitis, Irritant; Epidermis; Female; Filaggrin Proteins; Homeosta | 2004 |